CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- 4 Grant or award Chief Scientific Officer acquired 38,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 50,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 130,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 30,000 shares (grant or award)
- 4 Open-market sale Chief Operating Officer sold 2,543 shares at $7.15 ($18,182)
- 4 Open-market sale Chief Scientific Officer sold 1,266 shares at $7.18 ($9,090)
- 4 Open-market sale Chief Financial Officer sold 13,567 shares at $6.99 ($94,833)
- 4 Grant or award Chief Legal Officer acquired 61,000 shares (grant or award)
- 4 Planned sale Chief Scientific Officer sold 10,500 shares at $8.16 ($85,680)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Scientific Officer sold 5,500 shares at $10.80 ($59,400)
- 4 Planned sale Chief Scientific Officer sold 5,000 shares at $11.41 ($57,050)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 16 · 312 filings